Hyper-expression of PAX2 in human metastatic prostate tumors and its role as a cancer promoter in an in vitro invasion model
Authors:
Open Access
- 14 June 2013
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 73 (13) , 1403-1412
Abstract
BACKGROUND Metastasis is a consequence of many biological events, during which cancer stem cells are shifted into a malignant state. Among these events, invasion of prostate cancer cells into host tissues is possible to be assessed by means of an in vitro invasion model, and is thought to be coupled to altered expression of membrane proteins. Dysregulated functions of the factors regulating organogenesis during embryogenesis are known to facilitate metastasis of many types of cancers. PAX2 (paired box 2) is a member of the PAX transcription factor family, which regulates prostatic ductal growth and branching in organogenesis of mammalian prostates. However, the role of PAX2 in prostate cancer development remains to be determined. METHODS PAX2 expression in human prostate cancers and normal prostate epithelium were examined by quantitative RT‐PCR and immunohistochemistry. Matrigel invasion assay and a gene array analysis were performed using prostate cancer cell lines transfected with either control or PAX2 siRNA. RESULTS In human prostate cancers, PAX2 was hyper‐expressed in metastatic cancers, but was expressed at lower levels in non‐metastatic cancers. Consistent with this, PAX2 knockdown repressed cell growth and invasion in a Matrigel invasion assay. Gene ontology analysis revealed that many cell membrane proteins were downregulated after PAX2 knockdown. CONCLUSIONS Our data suggested that PAX2 hyper‐expression promotes the development of the metastatic state in prostate cancer cells, presumably through upregulating the expression of cell membrane proteins. Prostate 73: 1403–1412, 2013.Keywords
This publication has 24 references indexed in Scilit:
- Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor CellsCancer Research, 2012
- Oestrogen receptor–co‐factor–chromatin specificity in the transcriptional regulation of breast cancerThe EMBO Journal, 2011
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Cancer/Testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomyJournal of Translational Medicine, 2011
- The role of Pax2 in mouse prostate developmentThe Prostate, 2011
- RETRACTED: Testis-specific protein on Y chromosome ( TSPY ) represses the activity of the androgen receptor in androgen-dependent testicular germ-cell tumorsProceedings of the National Academy of Sciences, 2010
- Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistanceNature Medicine, 2010
- The BRCT-Domain Containing Protein PTIP Links PAX2 to a Histone H3, Lysine 4 Methyltransferase ComplexDevelopmental Cell, 2007
- Cell adhesion and signalling by cadherins and Ig-CAMs in cancerNature Reviews Cancer, 2004
- EXPRESSION OF THE DEVELOPMENTAL AND ONCOGENIC PAX2 GENE IN HUMAN PROSTATE CANCERJournal of Urology, 2001